ID
35644
Description
Study ID: 103268 Clinical Study ID: 103268 Study Title: An Open Label, Randomised, Single Dose, Three-way Crossover Study to Investigate the Relative Bioavailability of Two Different Formulations of GSK163090 and the Effect of Food on the Pharmacokinetics of a Tablet Formulation in Healthy Male and Female Volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00536679 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK163090 capsule, fasted/fed Trade Name: N/A Study Indication: Depression; Depressive Disorder and Anxiety Disorders
Mots-clés
Versions (1)
- 13/03/2019 13/03/2019 -
Détendeur de droits
GSK group of companies
Téléchargé le
13 mars 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
the Effect of Food on the Pharmacokinetics of a Tablet Formulation - 103268
Adverse Events
- StudyEvent: ODM
Description
Serious Adverse Event
Description
SECTION 1
Alias
- UMLS CUI-1
- C1828479
- UMLS CUI-2
- C1519255
Description
Record one SAE diagnosis per line, or a sign/symptom if the diagnosis is not available. If a diagnosis subsequently becomes available, this then should be entered and the sign/symptom crossed out, initialled and dated by the investigator. A separate form should be used for each SAE. However, if multiple SAEs which are temporally or clinically related are apparent at the time of initial reporting then these may be reported on the same page.
Type de données
text
Alias
- UMLS CUI [1]
- C0011900
Description
Record the start date of the first occurrence of the SAE.
Type de données
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C1519255
Description
Record the start date of the first occurrence of the SAE.
Type de données
time
Alias
- UMLS CUI [1,1]
- C1301880
- UMLS CUI [1,2]
- C1519255
Description
All SAEs must be followed until the events are resolved, the condition stabilises, the events are otherwise explained, or the subject is lost to follow-up. Indicate if the event was ’Recovered/Resolved’ or ’Recovered/Resolved with sequelae’. If the SAE is ongoing at the time the subject completes the study or becomes lost to follow-up, the outcome must be recorded as ’Not recovered/Not resolved’ or ’Recovering/Resolving’. Also enter ’Not recovered/Not resolved’ if the SAE was ongoing at the time of death, but was not the cause of death, enter fatal for the SAE which was the direct cause of death.
Type de données
integer
Alias
- UMLS CUI [1,1]
- C1705586
- UMLS CUI [1,2]
- C1519255
Description
Record the end date. This is the date the SAE Recovered/Resolved, or if the outcome was fatal, record the date the subject died. If the event Recovered/ Resolved with sequelae, enter the date the subject’s medical condition resolved or stabilised. Leave blank if the SAE is ’Not recovered/Not resolved’ or ’Recovering/Resolving’.
Type de données
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C1519255
Description
Record the end time of the SAE.
Type de données
time
Alias
- UMLS CUI [1,1]
- C1522314
- UMLS CUI [1,2]
- C1519255
Description
Record the maximum intensity that occurred over the duration of the event. Amend the intensity if it increases. Mild = An event that is easily tolerated by the subject, causing minimal discomfort and not interfering with everyday activities. Moderate = An event that is sufficiently discomforting to interfere with everyday activities. Severe = An event that prevents normal everyday activities. Not applicable = Those event(s) where intensity is meaningless or impossible to determine (i.e., blindness and coma).
Type de données
text
Alias
- UMLS CUI [1,1]
- C1710056
- UMLS CUI [1,2]
- C1519255
Description
Investigational product(s) withdrawn = Dose reduced = Dose increased = Dose not changed = Dose interrupted = Not applicable = Administration of investigational product(s) was permanently discontinued. Dose is reduced for one or more investigational product(s). Dose increased for one or more investigational product(s). Investigational product(s) continues even though an adverse event has occurred. Administration of one or more investigational product(s) was temporarily interrupted but then restarted. Subject was not receiving investigational product(s) when the event occurred (e.g., pre-or post-dosing) or the subject died and there was no prior decision to discontinue IP(s).
Type de données
text
Alias
- UMLS CUI [1,1]
- C1704758
- UMLS CUI [1,2]
- C1519255
Description
Indicate ’Yes’ if the event(s) were directly responsible for the subject’s withdrawal as indicated on the Study Conclusion page, otherwise indicate ’No’. If yes: Complete Study Conclusion page and check Adverse event as reason for withdrawal.
Type de données
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C1519255
Description
It is a regulatory requirement for investigators to assess relationship to investigational product(s) based on information available. The assessment should be reviewed on receipt of any new information and amended if necessary. ’A reasonable possibility’ is meant to convey that there are facts/evidence or arguments to suggest a causal relationship. Facts/evidence or arguments that may support ’a reasonable possibility’ include, e.g., a temporal relationship, a pharmacologically-predicted event, or positive dechallenge or rechallenge. Confounding factors, such as concomitant medication, a concurrent illness, or relevant medical history, should also be considered.
Type de données
text
Alias
- UMLS CUI [1,1]
- C0085978
- UMLS CUI [1,2]
- C1519255
Description
Section 2: Seriousness
Description
SAE results in death
Type de données
boolean
Alias
- UMLS CUI [1]
- C0011065
Description
SAE is life-threatening
Type de données
boolean
Alias
- UMLS CUI [1]
- C2826244
Description
SAE requires hospitalisation
Type de données
boolean
Alias
- UMLS CUI [1]
- C0019993
Description
SAE results in disability/incapacity
Type de données
boolean
Alias
- UMLS CUI [1]
- C0231170
Description
Congenital anomaly/birth defect
Type de données
boolean
Alias
- UMLS CUI [1]
- C0000768
Description
Óther SAE
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C1880177
Description
Other SAE specificationn
Type de données
text
Alias
- UMLS CUI [1]
- C3845569
Description
SECTION 3: Demography Data
Alias
- UMLS CUI-1
- C0011298
- UMLS CUI-2
- C1828479
Description
SECTION 4
Alias
- UMLS CUI-1
- C1828479
Description
Section 5
Alias
- UMLS CUI-1
- C0015127
- UMLS CUI-2
- C1519255
Description
Possible Causes of SAE Other Than Investigational Product(s)
Type de données
text
Alias
- UMLS CUI [1,1]
- C0015127
- UMLS CUI [1,2]
- C1519255
Description
If
Type de données
text
Alias
- UMLS CUI [1,1]
- C2348235
- UMLS CUI [1,2]
- C0012634
Description
If "Concomitant medication(s)", specify:
Type de données
text
Alias
- UMLS CUI [1,1]
- C2348235
- UMLS CUI [1,2]
- C2347852
Description
If "Other", specify:
Type de données
text
Alias
- UMLS CUI [1]
- C2348235
Description
SECTION 6: RELEVANT Medical Conditions
Alias
- UMLS CUI-1
- C0262926
Description
Relevant Medical Conditions
Type de données
text
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0262926
- UMLS CUI [1,3]
- C1519255
Description
Date of onset
Type de données
date
Alias
- UMLS CUI [1]
- C0574845
Description
continuation SAE
Type de données
text
Alias
- UMLS CUI [1,1]
- C0805733
- UMLS CUI [1,2]
- C1519255
Description
Date of Last Occurrence
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C2745955
Description
Section 7
Description
SECTION 8 RELEVANT Concomitant Medications
Alias
- UMLS CUI-1
- C1828479
- UMLS CUI-2
- C2347852
Description
Drug Name
Type de données
text
Alias
- UMLS CUI [1]
- C0013227
Description
Dose
Type de données
integer
Alias
- UMLS CUI [1]
- C3174092
Description
Unit
Type de données
text
Alias
- UMLS CUI [1]
- C1519795
Description
Frequency
Type de données
text
Alias
- UMLS CUI [1]
- C3476109
Description
Route
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Taken Prior to Study?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2826667
Description
Start Date
Type de données
date
Alias
- UMLS CUI [1]
- C0808070
Description
Stop Date
Type de données
date
Alias
- UMLS CUI [1]
- C0806020
Description
Ongoing Medication?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2826666
Description
Reason for Medication
Type de données
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013227
Description
Section 9 - Investigational Product
Description
Section 10
Description
Details of relevant assessments
Type de données
text
Alias
- UMLS CUI [1,1]
- C1261322
- UMLS CUI [1,2]
- C1519255
Description
SECTION 11 Narrative Remarks
Alias
- UMLS CUI-1
- C1828479
- UMLS CUI-2
- C0947611
Description
Investigator's signature
Alias
- UMLS CUI-1
- C2346576
Description
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Type de données
text
Alias
- UMLS CUI [1]
- C2346576
Description
Investigator signature date
Type de données
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Description
Investigator name
Type de données
text
Alias
- UMLS CUI [1]
- C2826892
Similar models
Adverse Events
- StudyEvent: ODM
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C1880177 (UMLS CUI [1,2])
C1828479 (UMLS CUI-2)
C0034897 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0262926 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C1519255 (UMLS CUI [1,2])
C2745955 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C2347852 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0947611 (UMLS CUI-2)
C1519255 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])